Solid Tumor Therapeutics Market Size, Type Analysis, Application Analysis, End-Use, Industry Analysis, Regional Outlook, Competitive Strategies And Forecasts, 2023-2032

  • Report ID: ME_0079780
  • Format: Electronic (PDF)
  • Publish Type:
  • Number of Pages: 250
Home Healthcare solid tumor therapeutics market....
  • Single User $3500
  • Multi User $4500
  • Enterprise User $5500

Market Snapshot

CAGR:9.49
2023
2032

Source: Market Expertz

RND-Favicon
Study Period 2019-2032
Base Year 2023
Forcast Year 2023-2032
CAGR 9.49
Healthcare-companies
Healthcare-Snapshot

Gain accurate insights regarding the negative impacts of COVID-19 on all markets and industries

Download Sample Pdf
Download Sample Pdf

Report Overview

Summary

In cancer, solid tumors are formed by aggregation of abnormal tissues that do not comprise of any liquid or cyst.
Increasing incidences of solid tumor among cancer patients and growing prevalence of various types of metastatic cancers are the major factors that are expected to drive the growth of the global solid tumor therapeutics market.
In 2018, the global Solid Tumor Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2026, with a CAGR of xx% between 2019 and 2026.

This report studies the Solid Tumor Therapeutics market size by players, regions, product types and end industries, history data 2014-2018 and forecast data 2019-2026; This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.

This report focuses on the global top players, covered
Hoffmann-La Roche
Johnson & Johnson
Novartis
AstraZeneca
Biogen Idec
Boehringer Ingelheim
GlaxoSmithKline
Eli Lilly
Kyowa Hakko Kirin
Abbott Laboratories
Baxter International

Market segment by Regions/Countries, this report covers
North America
Europe
China
Rest of Asia Pacific
Central & South America
Middle East & Africa

Market segment by Type, the product can be split into
Chemotherapy
Hormone Therapy
Immunotherapy
Targeted Therapy

Market segment by Application, the market can be split into
Breast Cancer
Lung Cancer
Colorectal Cancer
Prostate Cancer
Cervical Cancer
Others

The study objectives of this report are:
To study and forecast the market size of Solid Tumor Therapeutics in global market.
To analyze the global key players, SWOT analysis, value and global market share for top players.
To define, describe and forecast the market by type, end use and region.
To analyze and compare the market status and forecast among global major regions.
To analyze the global key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Solid Tumor Therapeutics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2026
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders
Raw material suppliers
Distributors/traders/wholesalers/suppliers
Regulatory bodies, including government agencies and NGO
Commercial research & development (R&D) institutions
Importers and exporters
Government organizations, research organizations, and consulting firms
Trade associations and industry bodies
End-use industries

Available Customizations
With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:
Further breakdown of Solid Tumor Therapeutics market on basis of the key contributing countries.
Detailed analysis and profiling of additional market players.
Table of Contents

Solid Tumor Therapeutics Market Report by Company, Regions, Types and Applications, Global Status and Forecast to 2025
1 Industry Overview of Solid Tumor Therapeutics
1.1 Solid Tumor Therapeutics Market Overview
1.1.1 Solid Tumor Therapeutics Product Scope
1.1.2 Market Status and Outlook
1.2 Global Solid Tumor Therapeutics Market Size and Analysis by Regions
1.2.1 North America
1.2.2 Europe
1.2.3 China
1.2.4 Rest of Asia Pacific
1.2.5 Central & South America
1.2.6 Middle East & Africa
1.3 Solid Tumor Therapeutics Market by Type
1.3.1 Chemotherapy
1.3.2 Hormone Therapy
1.3.3 Immunotherapy
1.3.4 Targeted Therapy
1.4 Solid Tumor Therapeutics Market by End Users/Application
1.4.1 Breast Cancer
1.4.2 Lung Cancer
1.4.3 Colorectal Cancer
1.4.4 Prostate Cancer
1.4.5 Cervical Cancer
1.4.6 Others

2 Global Solid Tumor Therapeutics Competition Analysis by Players
2.1 Solid Tumor Therapeutics Market Size (Value) by Players (2018 and 2019)
2.2 Competitive Status and Trend
2.2.1 Market Concentration Rate
2.2.2 Product/Service Differences
2.2.3 New Entrants
2.2.4 The Technology Trends in Future

3 Company (Top Players) Profiles
3.1 Hoffmann-La Roche
3.1.1 Company Profile
3.1.2 Main Business/Business Overview
3.1.3 Products, Services and Solutions
3.1.4 Solid Tumor Therapeutics Revenue (Value) (2014-2019)
3.1.5 Recent Developments
3.2 Johnson & Johnson
3.2.1 Company Profile
3.2.2 Main Business/Business Overview
3.2.3 Products, Services and Solutions
3.2.4 Solid Tumor Therapeutics Revenue (Value) (2014-2019)
3.2.5 Recent Developments
3.3 Novartis
3.3.1 Company Profile
3.3.2 Main Business/Business Overview
3.3.3 Products, Services and Solutions
3.3.4 Solid Tumor Therapeutics Revenue (Value) (2014-2019)
3.3.5 Recent Developments
3.4 AstraZeneca
3.4.1 Company Profile
3.4.2 Main Business/Business Overview
3.4.3 Products, Services and Solutions
3.4.4 Solid Tumor Therapeutics Revenue (Value) (2014-2019)
3.4.5 Recent Developments
3.5 Biogen Idec
3.5.1 Company Profile
3.5.2 Main Business/Business Overview
3.5.3 Products, Services and Solutions
3.5.4 Solid Tumor Therapeutics Revenue (Value) (2014-2019)
3.5.5 Recent Developments
3.6 Boehringer Ingelheim
3.6.1 Company Profile
3.6.2 Main Business/Business Overview
3.6.3 Products, Services and Solutions
3.6.4 Solid Tumor Therapeutics Revenue (Value) (2014-2019)
3.6.5 Recent Developments
3.7 GlaxoSmithKline
3.7.1 Company Profile
3.7.2 Main Business/Business Overview
3.7.3 Products, Services and Solutions
3.7.4 Solid Tumor Therapeutics Revenue (Value) (2014-2019)
3.7.5 Recent Developments
3.8 Eli Lilly
3.8.1 Company Profile
3.8.2 Main Business/Business Overview
3.8.3 Products, Services and Solutions
3.8.4 Solid Tumor Therapeutics Revenue (Value) (2014-2019)
3.8.5 Recent Developments
3.9 Kyowa Hakko Kirin
3.9.1 Company Profile
3.9.2 Main Business/Business Overview
3.9.3 Products, Services and Solutions
3.9.4 Solid Tumor Therapeutics Revenue (Value) (2014-2019)
3.9.5 Recent Developments
3.10 Abbott Laboratories
3.10.1 Company Profile
3.10.2 Main Business/Business Overview
3.10.3 Products, Services and Solutions
3.10.4 Solid Tumor Therapeutics Revenue (Value) (2014-2019)
3.10.5 Recent Developments
3.11 Baxter International

4 Global Solid Tumor Therapeutics Market Size by Type and Application (2014-2019)
4.1 Global Solid Tumor Therapeutics Market Size by Type (2014-2019)
4.2 Global Solid Tumor Therapeutics Market Size by Application (2014-2019)
4.3 Potential Application of Solid Tumor Therapeutics in Future
4.4 Top Consumer/End Users of Solid Tumor Therapeutics

5 North America Solid Tumor Therapeutics Development Status and Outlook
5.1 North America Solid Tumor Therapeutics Market Size (2014-2019)
5.2 North America Solid Tumor Therapeutics Market Size and Market Share by Players (2018 and 2019)

6 Europe Solid Tumor Therapeutics Development Status and Outlook
6.1 Europe Solid Tumor Therapeutics Market Size (2014-2019)
6.2 Europe Solid Tumor Therapeutics Market Size and Market Share by Players (2018 and 2019)

7 China Solid Tumor Therapeutics Development Status and Outlook
7.1 China Solid Tumor Therapeutics Market Size (2014-2019)
7.2 China Solid Tumor Therapeutics Market Size and Market Share by Players (2018 and 2019)

8 Rest of Asia Pacific Solid Tumor Therapeutics Development Status and Outlook
8.1 Rest of Asia Pacific Solid Tumor Therapeutics Market Size (2014-2019)
8.2 Rest of Asia Pacific Solid Tumor Therapeutics Market Size and Market Share by Players (2018 and 2019)

9 Central & South America Solid Tumor Therapeutics Development Status and Outlook
9.1 Central & South America Solid Tumor Therapeutics Market Size (2014-2019)
9.2 Central & South America Solid Tumor Therapeutics Market Size and Market Share by Players (2018 and 2019)

10 Middle East & Africa Solid Tumor Therapeutics Development Status and Outlook
10.1 Middle East & Africa Solid Tumor Therapeutics Market Size (2014-2019)
10.2 Middle East & Africa Solid Tumor Therapeutics Market Size and Market Share by Players (2018 and 2019)

11 Market Forecast by Regions, Type and Application (2019-2025)
11.1 Global Solid Tumor Therapeutics Market Size (Value) by Regions (2019-2025)
11.1.1 North America Solid Tumor Therapeutics Revenue and Growth Rate (2019-2025)
11.1.2 Europe Solid Tumor Therapeutics Revenue and Growth Rate (2019-2025)
11.1.3 China Solid Tumor Therapeutics Revenue and Growth Rate (2019-2025)
11.1.4 Rest of Asia Pacific Solid Tumor Therapeutics Revenue and Growth Rate (2019-2025)
11.1.5 Central & South America Solid Tumor Therapeutics Revenue and Growth Rate (2019-2025)
11.1.6 Middle East & Africa Solid Tumor Therapeutics Revenue and Growth Rate (2019-2025)
11.2 Global Solid Tumor Therapeutics Market Size (Value) by Type (2019-2025)
11.3 Global Solid Tumor Therapeutics Market Size by Application (2019-2025)

12 Solid Tumor Therapeutics Market Dynamics
12.1 Solid Tumor Therapeutics Market Opportunities
12.2 Solid Tumor Therapeutics Challenge and Risk
12.2.1 Competition from Opponents
12.2.2 Downside Risks of Economy
12.3 Solid Tumor Therapeutics Market Constraints and Threat
12.3.1 Threat from Substitute
12.3.2 Government Policy
12.3.3 Technology Risks
12.4 Solid Tumor Therapeutics Market Driving Force
12.4.1 Growing Demand from Emerging Markets
12.4.2 Potential Application

13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs Trend/Customer Preference
13.3 External Environmental Change
13.3.1 Economic Fluctuations
13.3.2 Other Risk Factors

14 Research Finding/Conclusion

15 Appendix
Methodology
Analyst Introduction
Data Source


List of Tables and Figures

Figure Solid Tumor Therapeutics Product Scope
Figure Global Solid Tumor Therapeutics Market Size (Million USD) (2014-2019)
Table Global Solid Tumor Therapeutics Market Size (Million USD) and Growth Rate by Regions (2014-2019)
Figure Global Solid Tumor Therapeutics Market Share by Regions in 2018
Figure North America Solid Tumor Therapeutics Market Size (Million USD) and Growth Rate by Regions (2014-2019)
Figure Europe Solid Tumor Therapeutics Market Size (Million USD) and Growth Rate by Regions (2014-2019)
Figure China Solid Tumor Therapeutics Market Size (Million USD) and Growth Rate by Regions (2014-2019)
Figure Rest of Asia Pacific Solid Tumor Therapeutics Market Size (Million USD) and Growth Rate by Regions (2014-2019)
Figure Central & South America Solid Tumor Therapeutics Market Size (Million USD) and Growth Rate by Regions (2014-2019)
Figure Middle East & Africa Solid Tumor Therapeutics Market Size (Million USD) and Growth Rate by Regions (2014-2019)
Figure Global Solid Tumor Therapeutics Market Share by Type in 2018
Figure Chemotherapy Market Size (Million USD) and Growth Rate (2014-2019)
Figure Hormone Therapy Market Size (Million USD) and Growth Rate (2014-2019)
Figure Immunotherapy Market Size (Million USD) and Growth Rate (2014-2019)
Figure Targeted Therapy Market Size (Million USD) and Growth Rate (2014-2019)
Figure Global Solid Tumor Therapeutics Market Share by Application in 2018
Table Key Downstream Customer in Breast Cancer
Figure Solid Tumor Therapeutics Market Size (Million USD) and Growth Rate in Breast Cancer (2014-2019)
Table Key Downstream Customer in Lung Cancer
Figure Solid Tumor Therapeutics Market Size (Million USD) and Growth Rate in Lung Cancer (2014-2019)
Table Key Downstream Customer in Colorectal Cancer
Figure Solid Tumor Therapeutics Market Size (Million USD) and Growth Rate in Colorectal Cancer (2014-2019)
Table Key Downstream Customer in Prostate Cancer
Figure Solid Tumor Therapeutics Market Size (Million USD) and Growth Rate in Prostate Cancer (2014-2019)
Table Key Downstream Customer in Cervical Cancer
Figure Solid Tumor Therapeutics Market Size (Million USD) and Growth Rate in Cervical Cancer (2014-2019)
Table Key Downstream Customer in Others
Figure Solid Tumor Therapeutics Market Size (Million USD) and Growth Rate in Others (2014-2019)
Table Solid Tumor Therapeutics Market Size (Million USD) by Players (2018 and 2019)
Figure Solid Tumor Therapeutics Market Size Share by Players in 2018
Figure Solid Tumor Therapeutics Market Size Share by Players in 2019
Table Hoffmann-La Roche Basic Information List
Table Solid Tumor Therapeutics Business Revenue (Million USD) of Hoffmann-La Roche (2014-2019)
Figure Hoffmann-La Roche Solid Tumor Therapeutics Business Revenue Market Share in 2018
Table Johnson & Johnson Basic Information List
Table Solid Tumor Therapeutics Business Revenue (Million USD) of Johnson & Johnson (2014-2019)
Figure Johnson & Johnson Solid Tumor Therapeutics Business Revenue Market Share in 2018
Table Novartis Basic Information List
Table Solid Tumor Therapeutics Business Revenue (Million USD) of Novartis (2014-2019)
Figure Novartis Solid Tumor Therapeutics Business Revenue Market Share in 2018
Table AstraZeneca Basic Information List
Table Solid Tumor Therapeutics Business Revenue (Million USD) of AstraZeneca (2014-2019)
Figure AstraZeneca Solid Tumor Therapeutics Business Revenue Market Share in 2018
Table Biogen Idec Basic Information List
Table Solid Tumor Therapeutics Business Revenue (Million USD) of Biogen Idec (2014-2019)
Figure Biogen Idec Solid Tumor Therapeutics Business Revenue Market Share in 2018
Table Boehringer Ingelheim Basic Information List
Table Solid Tumor Therapeutics Business Revenue (Million USD) of Boehringer Ingelheim (2014-2019)
Figure Boehringer Ingelheim Solid Tumor Therapeutics Business Revenue Market Share in 2018
Table GlaxoSmithKline Basic Information List
Table Solid Tumor Therapeutics Business Revenue (Million USD) of GlaxoSmithKline (2014-2019)
Figure GlaxoSmithKline Solid Tumor Therapeutics Business Revenue Market Share in 2018
Table Eli Lilly Basic Information List
Table Solid Tumor Therapeutics Business Revenue (Million USD) of Eli Lilly (2014-2019)
Figure Eli Lilly Solid Tumor Therapeutics Business Revenue Market Share in 2018
Table Kyowa Hakko Kirin Basic Information List
Table Solid Tumor Therapeutics Business Revenue (Million USD) of Kyowa Hakko Kirin (2014-2019)
Figure Kyowa Hakko Kirin Solid Tumor Therapeutics Business Revenue Market Share in 20187
Table Abbott Laboratories Basic Information List
Table Solid Tumor Therapeutics Business Revenue (Million USD) of Abbott Laboratories (2014-2019)
Figure Abbott Laboratories Solid Tumor Therapeutics Business Revenue Market Share in 2018
Table Baxter International Basic Information List
Table Global Solid Tumor Therapeutics Market Size (Million USD) by Type (2014-2019)
Figure Global Solid Tumor Therapeutics Market Size Share by Type in 2014
Figure Global Solid Tumor Therapeutics Market Size Share by Type in 2015
Figure Global Solid Tumor Therapeutics Market Size Share by Type in 2016
Figure Global Solid Tumor Therapeutics Market Size Share by Type in 2017
Figure Global Solid Tumor Therapeutics Market Size Share by Type in 2018
Figure Global Solid Tumor Therapeutics Market Size Share by Type in 2019
Table Global Solid Tumor Therapeutics Market Size (Million USD) by Application (2014-2019)
Figure Global Solid Tumor Therapeutics Market Size (Million USD) by Application in 2014
Figure Global Solid Tumor Therapeutics Market Size (Million USD) by Application in 2015
Figure Global Solid Tumor Therapeutics Market Size (Million USD) by Application in 2015
Figure Global Solid Tumor Therapeutics Market Size (Million USD) by Application in 2017
Figure Global Solid Tumor Therapeutics Market Size (Million USD) by Application in 2018
Figure Global Solid Tumor Therapeutics Market Size (Million USD) by Application in 2019
Table Top Consumer/End Users of Solid Tumor Therapeutics
Figure North America Solid Tumor Therapeutics Market Size (Million USD) and Growth Rate by Regions (2014-2019)
Table North America Solid Tumor Therapeutics Market Size (Million USD) by Players (2014-2019)
Figure North America Solid Tumor Therapeutics Market Size Share by Players in 2018
Figure North America Solid Tumor Therapeutics Market Size Share by Players in 2019
Figure Europe Solid Tumor Therapeutics Market Size (Million USD) and Growth Rate by Regions (2014-2019)
Table Europe Solid Tumor Therapeutics Market Size (Million USD) by Players (2014-2019)
Figure Europe Solid Tumor Therapeutics Market Size Share by Players in 2018
Figure Europe Solid Tumor Therapeutics Market Size Share by Players in 2019
Figure China Solid Tumor Therapeutics Market Size (Million USD) and Growth Rate by Regions (2014-2019)
Table China Solid Tumor Therapeutics Market Size (Million USD) by Players (2014-2019)
Figure China Solid Tumor Therapeutics Market Size Share by Players in 2018
Figure China Solid Tumor Therapeutics Market Size Share by Players in 2019
Figure Rest of Asia Pacific Solid Tumor Therapeutics Market Size (Million USD) and Growth Rate by Regions (2014-2019)
Table Rest of Asia Pacific Solid Tumor Therapeutics Market Size (Million USD) by Players (2014-2019)
Figure Rest of Asia Pacific Solid Tumor Therapeutics Market Size Share by Players in 2018
Figure Rest of Asia Pacific Solid Tumor Therapeutics Market Size Share by Players in 2019
Figure Central & South America Solid Tumor Therapeutics Market Size (Million USD) and Growth Rate by Regions (2014-2019)
Table Central & South America Solid Tumor Therapeutics Market Size (Million USD) by Players (2014-2019)
Figure Central & South America Solid Tumor Therapeutics Market Size Share by Players in 2018
Figure Central & South America Solid Tumor Therapeutics Market Size Share by Players in 2019
Figure Middle East & Africa Solid Tumor Therapeutics Market Size (Million USD) and Growth Rate by Regions (2014-2019)
Table Middle East & Africa Solid Tumor Therapeutics Market Size (Million USD) by Players (2014-2019)
Figure Middle East & Africa Solid Tumor Therapeutics Market Size Share by Players in 2018
Figure Middle East & Africa Solid Tumor Therapeutics Market Size Share by Players in 2019
Figure Global Solid Tumor Therapeutics Market Size (Million USD) by Regions (2019-2025)
Table Global Solid Tumor Therapeutics Market Size (Million USD) by Regions (2019-2025)
Figure Global Solid Tumor Therapeutics Market Size Share by Regions in 2019
Figure Global Solid Tumor Therapeutics Market Size Share by Regions in 2025
Figure North America Solid Tumor Therapeutics Revenue (Million USD) and Growth Rate (2019-2025)
Figure Europe Solid Tumor Therapeutics Revenue (Million USD) and Growth Rate (2019-2025)
Figure China Solid Tumor Therapeutics Revenue (Million USD) and Growth Rate (2019-2025)
Figure Rest of Asia Pacific Solid Tumor Therapeutics Revenue (Million USD) and Growth Rate (2019-2025)
Figure Central & South America Solid Tumor Therapeutics Revenue (Million USD) and Growth Rate (2019-2025)
Figure Middle East & Africa Solid Tumor Therapeutics Revenue (Million USD) and Growth Rate (2019-2025)
Table Global Solid Tumor Therapeutics Market Size (Million USD) by Type (2019-2025)
Figure Global Solid Tumor Therapeutics Market Size Share by Type in 2019
Figure Global Solid Tumor Therapeutics Market Size Share by Type in 2025
Table Global Solid Tumor Therapeutics Market Size (Million USD) by Application (2019-2025)
Figure Global Solid Tumor Therapeutics Market Size (Million USD) by Application in 2019
Figure Global Solid Tumor Therapeutics Market Size (Million USD) by Application in 2025

RESEARCH METHODOLOGY

A research methodology is a systematic approach for assessing or conducting a market study. Researchers tend to draw on a variety of both qualitative and quantitative study methods, inclusive of investigations, survey, secondary data and market observation.

Such plans can focus on classifying the products offered by leading market players or simply use statistical models to interpret observations or test hypotheses. While some methods aim for a detailed description of the factors behind an observation, others present the context of the current market scenario.

Now letā€™s take a closer look at the research methods here.

Secondary Research Model

Extensive data is obtained and cumulated on a substantial basis during the inception phase of the research process. The data accumulated is consistently filtered through validation from the in-house database, paid sources as well reputable industry magazines. A robust research study requires an understanding of the overall value chain. Annual reports and financials of industry players are studied thoroughly to have a comprehensive idea of the market taxonomy.

Primary Insights

Post conglomeration of the data obtained through secondary research; a validation process is initiated to verify the numbers or figures. This process is usually performed by having a detailed discussion with the industry experts.

However, we do not restrict our primary interviews only to the industry leaders. Our team covers the entire value chain while verifying the data. A significant number of raw material suppliers, local manufacturers, distributors, and stakeholders are interviewed to make our findings authentic. The current trends which include the drivers, restraints, and opportunities are also derived through the primary research process.

Market Estimation

The market estimation is conducted by analyzing the data collected through both secondary and primary research. This process involves market breakdown, bottom-up and top- down approach.

Moreover, while forecasting the market a comprehensive statistical time series model is designed for each market. Macroeconomic indicators are considered to understand the current trends of the market. Each data point is verified by the process of data triangulation method to arrive at the final market estimates.

Final Presentation

The penultimate process results in a holistic research report. The study equips key industry players to undertake significant strategic decisions through the findings. The report encompasses detailed market information. Graphical representations of the current market trends are also made available in order to make the study highly comprehensible for the reader.

You can also purchase parts of this report. Do you want to check out a section wise price list?

Personalized Business Report Tailored to Your Requirements

  • Our expert analysts collaborate directly with you to comprehend your specific needs.
  • Get data on regions, segments, competitors, and vendors of your choice.
  • Information is presented in alignment with your exact preferences and formatting.
Free Sample Report

"Find new revenue generation opportunities"